Cargando…
Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life
INTRODUCTION: Congenital anomalies of the kidney and urinary tract (CAKUT) are the predominant cause of chronic kidney disease (CKD) and the need for kidney replacement therapy (KRT) in children. Although more than 60 genes are known to cause CAKUT if mutated, genetic etiology is detected, on averag...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658255/ https://www.ncbi.nlm.nih.gov/pubmed/38025229 http://dx.doi.org/10.1016/j.ekir.2023.08.008 |
_version_ | 1785137379181330432 |
---|---|
author | Werfel, Lina Martens, Helge Hennies, Imke Gjerstad, Ann Christin Fröde, Kerstin Altarescu, Gheona Banerjee, Sushmita Valenzuela Palafoll, Irene Geffers, Robert Kirschstein, Martin Christians, Anne Bjerre, Anna Haffner, Dieter Weber, Ruthild G. |
author_facet | Werfel, Lina Martens, Helge Hennies, Imke Gjerstad, Ann Christin Fröde, Kerstin Altarescu, Gheona Banerjee, Sushmita Valenzuela Palafoll, Irene Geffers, Robert Kirschstein, Martin Christians, Anne Bjerre, Anna Haffner, Dieter Weber, Ruthild G. |
author_sort | Werfel, Lina |
collection | PubMed |
description | INTRODUCTION: Congenital anomalies of the kidney and urinary tract (CAKUT) are the predominant cause of chronic kidney disease (CKD) and the need for kidney replacement therapy (KRT) in children. Although more than 60 genes are known to cause CAKUT if mutated, genetic etiology is detected, on average, in only 16% of unselected CAKUT cases, making genetic testing unproductive. METHODS: Whole exome sequencing (WES) was performed in 100 patients with CAKUT diagnosed in the first 1000 days of life with CKD stages 1 to 5D/T. Variants in 58 established CAKUT-associated genes were extracted, classified according to the American College of Medical Genetics and Genomics guidelines, and their translational value was assessed. RESULTS: In 25% of these mostly sporadic patients with CAKUT, a rare likely pathogenic or pathogenic variant was identified in 1 or 2 of 15 CAKUT-associated genes, including GATA3, HNF1B, LIFR, PAX2, SALL1, and TBC1D1. Of the 27 variants detected, 52% were loss-of-function and 18.5% de novo variants. The diagnostic yield was significantly higher in patients requiring KRT before 3 years of age (43%, odds ratio 2.95) and in patients with extrarenal features (41%, odds ratio 3.5) compared with patients lacking these criteria. Considering that all affected genes were previously associated with extrarenal complications, including treatable conditions, such as diabetes, hyperuricemia, hypomagnesemia, and hypoparathyroidism, the genetic diagnosis allowed preventive measures and/or early treatment in 25% of patients. CONCLUSION: WES offers significant advantages for the diagnosis and management of patients with CAKUT diagnosed before 3 years of age, especially in patients who require KRT or have extrarenal anomalies. |
format | Online Article Text |
id | pubmed-10658255 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-106582552023-08-14 Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life Werfel, Lina Martens, Helge Hennies, Imke Gjerstad, Ann Christin Fröde, Kerstin Altarescu, Gheona Banerjee, Sushmita Valenzuela Palafoll, Irene Geffers, Robert Kirschstein, Martin Christians, Anne Bjerre, Anna Haffner, Dieter Weber, Ruthild G. Kidney Int Rep Translational Research INTRODUCTION: Congenital anomalies of the kidney and urinary tract (CAKUT) are the predominant cause of chronic kidney disease (CKD) and the need for kidney replacement therapy (KRT) in children. Although more than 60 genes are known to cause CAKUT if mutated, genetic etiology is detected, on average, in only 16% of unselected CAKUT cases, making genetic testing unproductive. METHODS: Whole exome sequencing (WES) was performed in 100 patients with CAKUT diagnosed in the first 1000 days of life with CKD stages 1 to 5D/T. Variants in 58 established CAKUT-associated genes were extracted, classified according to the American College of Medical Genetics and Genomics guidelines, and their translational value was assessed. RESULTS: In 25% of these mostly sporadic patients with CAKUT, a rare likely pathogenic or pathogenic variant was identified in 1 or 2 of 15 CAKUT-associated genes, including GATA3, HNF1B, LIFR, PAX2, SALL1, and TBC1D1. Of the 27 variants detected, 52% were loss-of-function and 18.5% de novo variants. The diagnostic yield was significantly higher in patients requiring KRT before 3 years of age (43%, odds ratio 2.95) and in patients with extrarenal features (41%, odds ratio 3.5) compared with patients lacking these criteria. Considering that all affected genes were previously associated with extrarenal complications, including treatable conditions, such as diabetes, hyperuricemia, hypomagnesemia, and hypoparathyroidism, the genetic diagnosis allowed preventive measures and/or early treatment in 25% of patients. CONCLUSION: WES offers significant advantages for the diagnosis and management of patients with CAKUT diagnosed before 3 years of age, especially in patients who require KRT or have extrarenal anomalies. Elsevier 2023-08-14 /pmc/articles/PMC10658255/ /pubmed/38025229 http://dx.doi.org/10.1016/j.ekir.2023.08.008 Text en © 2023 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Translational Research Werfel, Lina Martens, Helge Hennies, Imke Gjerstad, Ann Christin Fröde, Kerstin Altarescu, Gheona Banerjee, Sushmita Valenzuela Palafoll, Irene Geffers, Robert Kirschstein, Martin Christians, Anne Bjerre, Anna Haffner, Dieter Weber, Ruthild G. Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life |
title | Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life |
title_full | Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life |
title_fullStr | Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life |
title_full_unstemmed | Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life |
title_short | Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life |
title_sort | diagnostic yield and benefits of whole exome sequencing in cakut patients diagnosed in the first thousand days of life |
topic | Translational Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658255/ https://www.ncbi.nlm.nih.gov/pubmed/38025229 http://dx.doi.org/10.1016/j.ekir.2023.08.008 |
work_keys_str_mv | AT werfellina diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife AT martenshelge diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife AT henniesimke diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife AT gjerstadannchristin diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife AT frodekerstin diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife AT altarescugheona diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife AT banerjeesushmita diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife AT valenzuelapalafollirene diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife AT geffersrobert diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife AT kirschsteinmartin diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife AT christiansanne diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife AT bjerreanna diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife AT haffnerdieter diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife AT weberruthildg diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife |